Report updated May 19, 2026
Full Signal
For individuals undergoing GLP-1 therapies who require a low-friction, non-cluttered method to monitor their weekly medication and physical well-being.
Full Signal is an established health & fitness app that is available.
What is Full Signal?
Full Signal is a subscription-based health tracking app for individuals on GLP-1 therapies, focused on medication scheduling and symptom logging.
Users hire the app to maintain medication consistency and monitor physical well-being without the mental load of calorie counting or complex data entry.
Current Momentum
v1.0 · 3w ago
Active- Launched initial version in April 2026.
Active Nemesis
Shotsy GLP-1 Tracker
By Shotsy
Other Rivals
7-Day Rank Pulse 🇺🇸
Health & FitnessNo ranking data
Rating Pulse 🇺🇸
Gathering signals...
What makes this app unique?
Loading...
What Are The Key Features?
Weekly shot logging with pre-set medication, dose, and timing configurations
Visualization of user-reported feelings and trends over time
Low-friction interface for logging daily feelings without forms or scrolling
How much does it cost?
- Monthly subscription
- Yearly subscription
Subscription-only model gates all core tracking and insight features to ensure recurring revenue from the start.
Who Built It?
TRISTAN ROBERT NOHRER
Developing minimalist, low-friction digital tools for personal organization and casual entertainment. Focused on passive progression and daily habit tracking.
Portfolio
5
Apps
What other apps does TRISTAN ROBERT NOHRER make?
Explore the full TRISTAN ROBERT NOHRER report
Portfolio breakdown, audience, momentum, and every app published by TRISTAN ROBERT NOHRER.
What do users think recently?
Analysis in progress, available soon
What is the competitive landscape for Full Signal?
Where is it available?
Localized markets (1)
How's The Health & Fitness Market?
Market outlook for this category
Available very soon
Which niche is Full Signal in?
to track medication adherence and physical well-being
Explore the full Diabetes Management Trackers niche
Every app in this space — 46 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
Shotsy is the direct market leader for GLP-1 users, offering specialized medication tracking and side-effect monitoring that mirrors Full Signal's core value proposition.
Differentiators
- Provides advanced medication level estimation algorithms that Full Signal currently lacks for predictive insights
- Boasts a massive user base and high review volume, creating a strong social proof barrier
- Offers deep multi-medication scheduling capabilities that cater to complex patient treatment regimens
Head to head
Full Signal must pivot toward unique, actionable lifestyle insights to differentiate from Shotsy's clinical data-tracking dominance.
Contenders(4)
This is a direct feature-for-feature competitor that specifically targets the GLP-1 user demographic with similar tracking goals.
Differentiators
- Leverages Siri voice commands for hands-free logging, reducing friction for daily medication and symptom tracking
- Employs a local-first architecture that ensures user data remains on-device, contrasting with subscription-based cloud models
As a hospital-backed application, it competes by offering institutional credibility and direct access to medical records.
Cuspart targets the medical logging segment, appealing to users who prioritize professional-grade reporting and offline data security.
Differentiators
- Prioritizes local-only data privacy, appealing to users wary of cloud-based health tracking solutions
- Generates professional-grade PDF and CSV reports specifically formatted for physician review and clinical analysis
This app competes by targeting the broader metabolic health space, though it currently lacks the specialized focus of a dedicated GLP-1 tracker.
Same space(3)
GotCGM competes by offering high-end ecosystem integrations like CarPlay and Live Activities for constant data visibility.
Differentiators
- Offers deep Apple ecosystem integration including Live Activities and CarPlay for real-time data visibility
- Provides calendar integration to correlate health data with daily schedules and external events
This app serves the same metabolic health audience by providing a structured log for insulin and glucose management.
GlucoseWatch competes by focusing on the Apple ecosystem, specifically targeting users who want wrist-based health monitoring.
Compare Full Signal against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Full Signal
Strengths to defend, gaps to attack
Core Strengths
- Low-friction interface removes tracking burden
- Pattern-based insights provide value beyond raw logging
Critical Frictions
- Subscription-only model limits top-of-funnel conversion
- Lack of predictive medication-level modeling
Growth Levers
- Wearable health data integration
- B2B partnerships with clinics
Market Threats
- Established competitors with high review counts
- Predictive modeling updates from rivals
What are the next best moves?
Ship predictive medication-level modeling because it is the primary utility gap vs Shotsy → increase long-term retention
Competitor analysis identifies predictive modeling as a key differentiator for the market leader.
Trade-off: Deprioritize the planned UI theme customizer to reallocate engineering hours to core logic.
A counter-intuitive read
The subscription-only model is a strategic advantage, not a weakness, as it filters for high-intent users who value the app's 'no-clutter' promise over free, ad-heavy alternatives.
Feature Gaps vs Competitors
- Predictive medication level estimation (available in Shotsy)
- Multi-medication scheduling (available in Shotsy)
Key Takeaways
Full Signal succeeds by simplifying the GLP-1 tracking experience, but the lack of predictive clinical features leaves it vulnerable to established rivals, so the PM should prioritize adding medication-level modeling to defend against churn.
Where Is It Heading?
Stable
The GLP-1 tracking market is consolidating around apps that offer both ease-of-use and clinical utility. Full Signal's current posture is advantaged by its simplicity, but it must add predictive features to prevent users from migrating to more data-rich competitors.
The app launched recently with a focused feature set, establishing a baseline for future expansion into predictive health analytics.